Picture of Cogstate logo

CGS Cogstate Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual income statement for Cogstate, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
R2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue21.922.832.74541.2
Cost of Revenue
Gross Profit9.849.217.526.321.3
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses25.725.826.934.338.1
Operating Profit-3.85-2.995.8210.73.03
Net Income Before Taxes-3.85-2.995.8210.73.03
Provision for Income Taxes
Net Income After Taxes-2.5-1.965.237.523.57
Net Income Before Extraordinary Items
Net Income-2.5-1.965.237.523.57
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-2.5-1.965.237.523.57
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.021-0.0120.030.0430.02